Yusuf Sherwani, M.D., is CEO and Co-Founder of Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management. Together with his colleagues Maroof Ahmed, M.D., and Sarim Siddiqui, M.D., Yusuf developed a vision for the company’s technology-driven, evidence-based substance use disorder treatment platform. Tens of thousands of members enroll in the Pelago program each year to help manage their substance use and improve their lives, and today more than 3.4 million have access to the digital clinic.

A medical doctor by training and a technology enthusiast at heart, Yusuf is seen as an innovator operating at the intersection of healthcare, technology and design. With a medical degree from Imperial College London, Yusuf has co-authored 12 peer-reviewed studies on behavioral health and substance use disorders. He was featured in Forbes’ 30 Under 30 list (2018) as well as Fast Company’s 100 Most Creative People in Business. 

Pelago is a Y-Combinator backed company (Winter 2018 batch) that has raised more than $150 million to date from leading healthcare and technology investors.